Holen Sie sich die Stockscreener-App
1.33
6.40%
0.08
Handel nachbörslich:
1.31
-0.02
-1.50%
Schlusskurs vom Vortag:
$1.25
Offen:
$1.25
24-Stunden-Volumen:
107.32K
Relative Volume:
0.06
Marktkapitalisierung:
$10.89M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-2.5094
EPS:
-0.53
Netto-Cashflow:
$-22.36M
1W Leistung:
+6.40%
1M Leistung:
-2.92%
6M Leistung:
-10.14%
1J Leistung:
-68.26%
1-Tages-Spanne:
$1.2488
$1.35
1-Wochen-Bereich:
$1.18
$1.35
52-Wochen-Spanne:
$0.95
$4.22
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.33 | 10.89M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Is Evogene Ltd. vulnerable to short sellers2025 Earnings Impact & Consistent Income Trade Ideas - thegnnews.com
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - global-agriculture.com
Is Evogene Ltd. likely to announce a buybackFast Money Trade Selections - 한국정경신문
Evogene partners with Tel Aviv University to develop metabolic disease treatments - Investing.com Canada
Evogene and Tel Aviv University collaborate on drug discovery for metabolite-related diseases. - AInvest
Breakthrough: AI-Driven Drug Discovery Partnership Targets Tyrosinemia and Gout Treatment - Stock Titan
Evogene Ltd. stock daily chart insightsDownside Control Plan With Support Analysis - Newser
Evogene Ltd. recovery potential after sell offValue Investing Summary and Earnings Outlook - Newser
How Evogene Ltd. stock performs during market volatilityBuy and Hold Strategy for Capital Safety - Newser
Can Evogene Ltd. maintain sales growthSmart Entry for Explosive Returns - mustnews.co.kr
Will Evogene Ltd. see short term momentumWeekly Outlook for Short Term Investors - Newser
What MACD and RSI say about Evogene Ltd.ROI Focused Setup Screener With Exit Markers - Newser
Has Evogene Ltd. Stock Ever Crashed Historical Volatility ReviewDownside Control Plan With Support Analysis - Newser
Trapped Investors in Evogene Ltd. Await Breakout SignalVerified Signal From Chart Patterns Detected - beatles.ru
Published on: 2025-08-04 06:37:37 - Jammu Links News
What are Evogene Ltd. company’s key revenue driversCapitalize on emerging market trends - Jammu Links News
Is Evogene Ltd. stock overvalued or undervaluedAchieve consistent profits with expert strategies - Jammu Links News
What markets is EYEN expanding into Is Evogene Ltd. stock a good long term investment optionExtraordinary earning power - Jammu Links News
Does Evogene Ltd. stock perform well during market downturnsGet alerts on high-potential stock breakouts - Jammu Links News
What are the latest earnings results for Evogene Ltd.Build wealth faster with consistent growth stocks - Jammu Links News
What is the dividend policy of Evogene Ltd. stockUnstoppable investment returns - Jammu Links News
Should I hold or sell Evogene Ltd. stock in 2025Market-crushing stock picks - Jammu Links News
How many analysts rate Evogene Ltd. as a “Buy”Achieve consistent profits with disciplined trading - Jammu Links News
Why Evogene Ltd. stock attracts strong analyst attention200 Percent Profit Outlook - beatles.ru
Is Evogene Ltd. a growth stock or a value stockStock Market Ideas With Proven Results - Jammu Links News
Evogene Schedules Second Quarter 2025 Financial Results Release - 富途牛牛
What risks could impact Evogene Ltd. stock performanceConsistent Profit Pattern Recognition Tools Shared - metal.it
What makes Evogene Ltd. stock price move sharplyEntry and Exit Strategy Optimizer Tool Tested - beatles.ru
Evogene Announces Q2 2025 Financial Results Release, Schedules Zoom Conference Call for August 19, 2025. - AInvest
Computational Biology Leader Evogene Sets Q2 2025 Earnings Release DateKey Details Inside - Stock Titan
How does Evogene Ltd. compare to its industry peersPre Market Trend Scanner From AI Tools - jammulinksnews.com
Evogene Ltd. Company Revenue and Profit Trends: A Deep DiveExpert Verified Stock Trade Ideas Backed by Data - metal.it
What markets is Evogene Ltd. expanding into Is SBCF stock a good long term investment optionMaximize returns with smart investment plans - Jammu Links News
Why is Evogene Ltd. stock attracting strong analyst attentionPhenomenal capital gains - Jammu Links News
Is Evogene Ltd. a good long term investmentRemarkable growth - PrintWeekIndia
Evogene Ltd. Stock Analysis and ForecastExplosive earning power - PrintWeekIndia
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):